Health - HealthQuill

Johnson & Johnson’s investigational treatment to help people with a specific type of early-stage bladder cancer has shown 80% of the patients to be free of cancer for up to nine months, and 94% were able to avoid surgical removal of the organ after a year of follow-up.

J&J’s trial drug for a type of bladder cancer helps avoid organ removal

HQ Team April 27, 2025: Johnson & Johnson’s investigational treatment to help people with a specific type of early-stage bladder cancer has shown.

by HealthQuill
April 27, 2025
0 Comments

Uganda declared the Ebola disease outbreak, which started three months ago, has ended, according to the World Health Organization.

Drugs Health Pharma

Uganda declares Ebola disease outbreak to be over, WHO says

HQ Team April 26, 2025: Uganda declared the Ebola disease outbreak, which started three months ago, has ended, according to the World Health.

by HealthQuill
April 26, 2025
0 Comments

More than 84% of 345 information technology workers surveyed in an Indian city suffer from non-alcoholic fatty liver disease due to sedentary lifestyles, posing a significant health challenge, according to a study.

Drugs Health Research

In Hyderabad, India, 84% of IT workers have non-alcoholic fatty liver

HQ Team April 24, 2025: More than 84% of 345 information technology workers surveyed in an Indian city suffer from non-alcoholic fatty liver.

by HealthQuill
April 24, 2025
0 Comments

UNOPS stands for the United Nations Office for Project Services. It is a UN agency that implements humanitarian and development projects for the UN system, international financial institutions, and other partners. UNOPS provides infrastructure, procurement, and project management services to support peace and security, humanitarian, and development initiatives globally.

Drugs Health Pharma

UN body cuts price of medicine to combat multidrug-resistant TB

HQ Team April 23, 2025: A UN agency, the Stop TB Partnership’s Global Drug Facility (GDF), cut the price of pretomanid, a key.

by HealthQuill
April 23, 2025
0 Comments

Bristol Myers Squibb’s investigational oral drug for treating schizophrenia in adults failed in its main goal to treat symptoms in patients who are already on regular medication.

Drugs Health Pharma

Bristol Myers’ oral medication for schizophrenia fails to meet main goal

HQ Team April 23: Bristol Myers Squibb’s investigational oral drug for treating schizophrenia in adults failed in its main goal to treat symptoms.

by HealthQuill
April 23, 2025
0 Comments

Displacement caused by an internal conflict between the government and armed militants, weather extremes, and funding cuts is driving 10 million people in Ethiopia to malnutrition and hunger, a UN agency says.

Climate Drugs Health

Internal strife, funding cuts driving Ethiopians to hunger

HQ Team April 23, 2025: Displacement caused by an internal conflict between the government and armed militants, weather extremes, and funding cuts is.

by HealthQuill
April 23, 2025
0 Comments

Marvin Lee Minsky, an American cognitive and computer scientist who co-founded the Massachusetts Institute of Technology's AI laboratory and wrote extensively about AI and philosophy, suggested as early as 1985 that “AI should possess emotions.” Today, emotional AI has evolved beyond academic boundaries, and para-social relationships have become normal.

Health Opinion Research

AI & the Heart: How Machines Are Replacing Human Connection

April 22, 2025: In a world increasingly run by algorithms, it’s not just playlists or grocery orders—your feelings might be next. From digital.

by HealthQuill
April 22, 2025
0 Comments

Generic drugs made in India, which account for 93% of such medicines made from emerging countries, are linked to hospitalisation, disability and in a few cases death, compared to the US, according to a study by the Ohio State University.

Drugs Health Research

Generic Indian drugs have a 54% higher risk compared to US

HQ Team April 18, 2025: Generic drugs made in India, which account for 93% of such medicines made from emerging countries, are linked.

by HealthQuill
April 18, 2025
0 Comments

Britain’s Medicines and Healthcare products Regulatory Agency has authorised GSK Plc’s combination drug to treat patients with multiple myeloma who have received at least one prior therapy.

Drugs Health Pharma

Britain gives green light for GSK Plc’s treatment of rare blood cancer

HQ Team April 18, 2025: Britain’s Medicines and Healthcare products Regulatory Agency has authorised GSK Plc’s combination drug to treat patients with multiple.